Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Link:
Autor/in:
Erscheinungsjahr:
2010
Medientyp:
Text
Schlagworte:
  • Adult
  • Germany
  • Humans
  • Male
  • Aged
  • Female
  • Middle Aged
  • Aged, 80 and over
  • Immunohistochemistry
  • Prognosis
  • Time Factors
  • Retrospective Studies
  • Neoplasm Staging
  • Cell Proliferation
  • Kaplan-Meier Estimate
  • Tumor Markers, Biological analysis
  • Antigens, CD analysis
  • Antigens, CD31 analysis
  • Carcinoma, Pancreatic Ductal blood supply
  • Carcinoma, Papillary blood supply
  • Ki-67 Antigen analysis
  • Neoplasm Invasiveness
  • Neoplasms, Cystic, Mucinous, and Serous blood supply
  • Neovascularization, Pathologic metabolism
  • Pancreatic Neoplasms blood supply
  • Receptors, Cell Surface analysis
  • Adult
  • Germany
  • Humans
  • Male
  • Aged
  • Female
  • Middle Aged
  • Aged, 80 and over
  • Immunohistochemistry
  • Prognosis
  • Time Factors
  • Retrospective Studies
  • Neoplasm Staging
  • Cell Proliferation
  • Kaplan-Meier Estimate
  • Tumor Markers, Biological analysis
  • Antigens, CD analysis
  • Antigens, CD31 analysis
  • Carcinoma, Pancreatic Ductal blood supply
  • Carcinoma, Papillary blood supply
  • Ki-67 Antigen analysis
  • Neoplasm Invasiveness
  • Neoplasms, Cystic, Mucinous, and Serous blood supply
  • Neovascularization, Pathologic metabolism
  • Pancreatic Neoplasms blood supply
  • Receptors, Cell Surface analysis
Beschreibung:
  • Intraductal papillary-mucinous neoplasm (IPMN) of the pancreas is an increasingly diagnosed entity since its definition by the World Health Organization in 1996. It has a broad clinical spectrum ranging from benign to malignant tumors. Optimum treatment is controversial and a better understanding of the development of IPMN of the pancreas and identification of potential prognostic factors will help to address this. Angiogenesis plays an elementary role in the development of malignant tumors and may well also be important in the development of IPMN of the pancreas. Therefore we investigated endothelial cell marker CD31 (PECAM-1) and angiogenesis associated marker CD105 (endoglin) by immunohistochemistry.
  • Intraductal papillary-mucinous neoplasm (IPMN) of the pancreas is an increasingly diagnosed entity since its definition by the World Health Organization in 1996. It has a broad clinical spectrum ranging from benign to malignant tumors. Optimum treatment is controversial and a better understanding of the development of IPMN of the pancreas and identification of potential prognostic factors will help to address this. Angiogenesis plays an elementary role in the development of malignant tumors and may well also be important in the development of IPMN of the pancreas. Therefore we investigated endothelial cell marker CD31 (PECAM-1) and angiogenesis associated marker CD105 (endoglin) by immunohistochemistry.
Lizenz:
  • info:eu-repo/semantics/restrictedAccess
Quellsystem:
Forschungsinformationssystem des UKE

Interne Metadaten
Quelldatensatz
oai:pure.atira.dk:publications/f77f34a8-2e35-4730-b858-2e1f96bc00ff